Real World Evidence
The market landscape—in sharp focus
By collecting, analyzing, and communicating real-world evidence we present a scientific view of the marketplace to help you access new markets, better position your products with payers, providers, and patients, and realize the full potential of your brands.
Learn more about our approach 
-
Couple expert study design consultation with rich data sets to produce the real-world evidence you need to achieve both your scientific and commercial objectives while maintaining regulatory compliance.
Our late phase research team is uniquely positioned to deliver intelligence that allows you to address key areas throughout commercialization that include:
- Post-authorization safety studies (PASS) / Post-authorization efficacy studies (PAES)
- Phase IV trials—approved product, same indications (interventional)
- Registries—disease, product, and safety (observational)
- Consumer healthcare/OTC trials
- Community-based and naturalistic studies
- Health economic piggyback trials
- Scientific dissemination
Output from late phase initiatives underpins all of these solutions while a dedicated team of full-time employees supports your commercialization areas of concern with proven expertise. The level of integration and interconnectivity we deliver—providing you with all of your essential commercialization solutions under one roof—leads to greater efficiency and quality.
Learn more 
-
Health Economics and Outcomes Research
Leverage the proven expertise of one of the world’s leading health economics and outcomes research (HEOR) companies to:
- Develop a deeper understanding of your market
- Evaluate your portfolio’s health economics implications
- Choose between competing compounds in development
- Make more informed pricing decisions
- Increase formulary acceptance and reimbursement
- Devise strategies to address budgetary challenges
- Achieve greater differentiation for your products
- Demonstrate your products’ value in the market
- Gain competitive advantage and grow market share
Learn more
-
Develop robust, highly versatile economic models that combine the best available clinical, economic, and quality-of-life data to inform your decisions about product pricing, reimbursement, and market access.
Learn more
-
When it comes to drug safety and epidemiology, you want real insights, not just information. OptumInsight epidemiology experts are recognized for their scientific rigor and integrity.
Learn more